Roivant Sciences Ltd (ROIV)

Activity ratios

Short-term

Turnover ratios

Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Inventory turnover 0.45 0.44 3.92 5.14 6.05 8.36 0.24 0.10 0.17 0.19 0.05
Receivables turnover 143.89 5.54 1.91 1.97 2.26 2.58 1.97 1.63 1.46 1.84 8.21 5.30 3.46 5.54 1.72
Payables turnover 0.27 0.45 0.56 0.29 0.44 0.58 0.57 0.51 0.61 0.29 0.17 0.06 0.26 0.37 0.11 0.17 0.10
Working capital turnover 0.02 0.02 0.02 0.03 0.02 0.02 0.08 0.06 0.04 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.01

The activity ratios of Roivant Sciences Ltd provide insight into the efficiency of the company's operations in managing its assets and working capital.

1. Inventory turnover: This ratio indicates how many times during a period the company has sold and replaced its inventory. The trend for Roivant Sciences shows fluctuation, with a significant increase from March 2024 to June 2024. The latest value of 0.45 for June 30, 2024, indicates that the company is managing its inventory efficiently compared to previous periods.

2. Receivables turnover: This ratio measures how effectively the company is collecting on its credit sales. The trend for Roivant Sciences shows some fluctuations, with a sharp increase in December 2024, suggesting a higher efficiency in collecting receivables during that period.

3. Payables turnover: This ratio reflects how quickly the company pays its suppliers. Roivant Sciences' payables turnover ratio has been relatively stable over the periods, with values ranging between 0.10 to 0.61. A higher ratio indicates that the company is paying its suppliers more quickly.

4. Working capital turnover: This ratio assesses how efficiently the company is using its working capital to generate sales. Roivant Sciences' working capital turnover ratio has shown fluctuations over the periods, with values ranging from 0.01 to 0.08. A higher ratio indicates better efficiency in utilizing working capital to generate revenue.

Overall, analyzing these activity ratios provides valuable insights into Roivant Sciences Ltd's operational efficiency and effectiveness in managing its assets and working capital to support its business activities.


Average number of days

Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Days of inventory on hand (DOH) days 809.77 826.90 93.14 71.07 60.32 43.67 1,544.48 3,761.02 2,188.29 1,929.94 6,641.08
Days of sales outstanding (DSO) days 2.54 65.88 190.94 184.81 161.78 141.23 185.39 224.22 249.28 198.13 44.44 68.86 105.48 65.91 212.17
Number of days of payables days 1,331.57 808.79 649.99 1,267.76 826.32 626.16 639.34 714.37 598.34 1,238.14 2,093.71 5,917.18 1,407.85 989.50 3,399.24 2,092.44 3,646.45

Roivant Sciences Ltd's activity ratios show fluctuations in efficiency over the years.

- Days of Inventory on Hand (DOH):
- The DOH has shown a significant decrease from 6,641.08 days in June 2021 to 43.67 days in March 2023, before increasing to 809.77 days in June 2024. However, it then dropped to 0 days in December 2024 and March 2025, indicating potential issues with inventory management.

- Days of Sales Outstanding (DSO):
- The DSO improved from 212.17 days in March 2021 to 2.54 days in December 2024, suggesting more efficient sales collection processes. However, there were fluctuations over the years, indicating possible changes in sales terms or customer payment behavior.

- Number of Days of Payables:
- The number of days of payables decreased from 3,646.45 days in March 2021 to 598.34 days in March 2023 before increasing to 1,331.57 days in March 2025. This suggests changes in payment practices with suppliers.

Overall, improvements in DSO and DOH are positive indicators, but the increasing days of payables may signify potential cash flow challenges or strained supplier relationships that may need attention.


Long-term

Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Fixed asset turnover 1.41 2.17 1.57 1.16 1.29 1.64 2.13 2.83 2.52 0.37 0.31
Total asset turnover 0.01 0.02 0.02 0.02 0.02 0.02 0.05 0.04 0.03 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01

Roivant Sciences Ltd's long-term activity ratios indicate the efficiency of the company in utilizing its assets over an extended period. The Fixed Asset Turnover ratio, which measures how effectively the company generates revenue from its fixed assets, showed fluctuations over the years. The ratio saw a significant improvement from September 30, 2021, to December 31, 2022, indicating better utilization of fixed assets during this period. However, the ratio declined thereafter, possibly suggesting changes in the company's asset management strategy.

On the other hand, the Total Asset Turnover ratio, reflecting the company's overall efficiency in generating sales from all its assets, remained relatively low from December 31, 2020, to March 31, 2023, indicating a slower turnover of assets during this time. The ratio started to increase from March 31, 2023, reaching its peak on September 30, 2023, suggesting an improvement in the company's overall asset utilization efficiency.

Overall, the trends in both ratios indicate fluctuations in Roivant Sciences Ltd's efficiency in utilizing its assets to generate revenue over the years, highlighting the importance of carefully managing asset turnover to improve operational performance.